Global Rabies Diagnosis Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07243025

Publication Date:

July 16, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Rabies Diagnosis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩abies Diagnosis Industry Forecast鈥� looks at past sales and reviews total world Rabies Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Diagnosis sales for 2023 through 2029. With Rabies Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Rabies Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rabies Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Rabies Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Diagnosis.
United States market for Rabies Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Rabies Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Rabies Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Rabies Diagnosis players cover Bio-Rad Laboratories, Merck KGaA, Aviva Systems Biology, Creative Diagnostics, MyBioSource, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
ELISA
PCR
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
ELISA
PCR
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Merck KGaA
Aviva Systems Biology
Creative Diagnostics
MyBioSource
Abbexa Ltd
Norgen Biotek
EXPRESS BIOTECH INTERNATIONAL, INC.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rabies Diagnosis Market Size 2019-2030
2.1.2 Rabies Diagnosis Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Rabies Diagnosis by Country/Region, 2019, 2023 & 2030
2.2 Rabies Diagnosis Segment by Type
2.2.1 ELISA
2.2.2 PCR
2.2.3 Others
2.3 Rabies Diagnosis Market Size by Type
2.3.1 Rabies Diagnosis Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Rabies Diagnosis Market Size Market Share by Type (2019-2024)
2.4 Rabies Diagnosis Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Rabies Diagnosis Market Size by Application
2.5.1 Rabies Diagnosis Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Rabies Diagnosis Market Size Market Share by Application (2019-2024)
3 Rabies Diagnosis Market Size by Player
3.1 Rabies Diagnosis Market Size Market Share by Player
3.1.1 Global Rabies Diagnosis Revenue by Player (2019-2024)
3.1.2 Global Rabies Diagnosis Revenue Market Share by Player (2019-2024)
3.2 Global Rabies Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rabies Diagnosis by Region
4.1 Rabies Diagnosis Market Size by Region (2019-2024)
4.2 Global Rabies Diagnosis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rabies Diagnosis Market Size Growth (2019-2024)
4.4 APAC Rabies Diagnosis Market Size Growth (2019-2024)
4.5 Europe Rabies Diagnosis Market Size Growth (2019-2024)
4.6 Middle East & Africa Rabies Diagnosis Market Size Growth (2019-2024)
5 Americas
5.1 Americas Rabies Diagnosis Market Size by Country (2019-2024)
5.2 Americas Rabies Diagnosis Market Size by Type (2019-2024)
5.3 Americas Rabies Diagnosis Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Diagnosis Market Size by Region (2019-2024)
6.2 APAC Rabies Diagnosis Market Size by Type (2019-2024)
6.3 APAC Rabies Diagnosis Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rabies Diagnosis Market Size by Country (2019-2024)
7.2 Europe Rabies Diagnosis Market Size by Type (2019-2024)
7.3 Europe Rabies Diagnosis Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rabies Diagnosis by Region (2019-2024)
8.2 Middle East & Africa Rabies Diagnosis Market Size by Type (2019-2024)
8.3 Middle East & Africa Rabies Diagnosis Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rabies Diagnosis Market Forecast
10.1 Global Rabies Diagnosis Forecast by Region (2025-2030)
10.1.1 Global Rabies Diagnosis Forecast by Region (2025-2030)
10.1.2 Americas Rabies Diagnosis Forecast
10.1.3 APAC Rabies Diagnosis Forecast
10.1.4 Europe Rabies Diagnosis Forecast
10.1.5 Middle East & Africa Rabies Diagnosis Forecast
10.2 Americas Rabies Diagnosis Forecast by Country (2025-2030)
10.2.1 United States Market Rabies Diagnosis Forecast
10.2.2 Canada Market Rabies Diagnosis Forecast
10.2.3 Mexico Market Rabies Diagnosis Forecast
10.2.4 Brazil Market Rabies Diagnosis Forecast
10.3 APAC Rabies Diagnosis Forecast by Region (2025-2030)
10.3.1 China Rabies Diagnosis Market Forecast
10.3.2 Japan Market Rabies Diagnosis Forecast
10.3.3 Korea Market Rabies Diagnosis Forecast
10.3.4 Southeast Asia Market Rabies Diagnosis Forecast
10.3.5 India Market Rabies Diagnosis Forecast
10.3.6 Australia Market Rabies Diagnosis Forecast
10.4 Europe Rabies Diagnosis Forecast by Country (2025-2030)
10.4.1 Germany Market Rabies Diagnosis Forecast
10.4.2 France Market Rabies Diagnosis Forecast
10.4.3 UK Market Rabies Diagnosis Forecast
10.4.4 Italy Market Rabies Diagnosis Forecast
10.4.5 Russia Market Rabies Diagnosis Forecast
10.5 Middle East & Africa Rabies Diagnosis Forecast by Region (2025-2030)
10.5.1 Egypt Market Rabies Diagnosis Forecast
10.5.2 South Africa Market Rabies Diagnosis Forecast
10.5.3 Israel Market Rabies Diagnosis Forecast
10.5.4 Turkey Market Rabies Diagnosis Forecast
10.6 Global Rabies Diagnosis Forecast by Type (2025-2030)
10.7 Global Rabies Diagnosis Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Rabies Diagnosis Forecast
11 Key Players Analysis
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Information
11.1.2 Bio-Rad Laboratories Rabies Diagnosis Product Offered
11.1.3 Bio-Rad Laboratories Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bio-Rad Laboratories Main Business Overview
11.1.5 Bio-Rad Laboratories Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Rabies Diagnosis Product Offered
11.2.3 Merck KGaA Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Aviva Systems Biology
11.3.1 Aviva Systems Biology Company Information
11.3.2 Aviva Systems Biology Rabies Diagnosis Product Offered
11.3.3 Aviva Systems Biology Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Aviva Systems Biology Main Business Overview
11.3.5 Aviva Systems Biology Latest Developments
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Information
11.4.2 Creative Diagnostics Rabies Diagnosis Product Offered
11.4.3 Creative Diagnostics Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Creative Diagnostics Main Business Overview
11.4.5 Creative Diagnostics Latest Developments
11.5 MyBioSource
11.5.1 MyBioSource Company Information
11.5.2 MyBioSource Rabies Diagnosis Product Offered
11.5.3 MyBioSource Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 MyBioSource Main Business Overview
11.5.5 MyBioSource Latest Developments
11.6 Abbexa Ltd
11.6.1 Abbexa Ltd Company Information
11.6.2 Abbexa Ltd Rabies Diagnosis Product Offered
11.6.3 Abbexa Ltd Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbexa Ltd Main Business Overview
11.6.5 Abbexa Ltd Latest Developments
11.7 Norgen Biotek
11.7.1 Norgen Biotek Company Information
11.7.2 Norgen Biotek Rabies Diagnosis Product Offered
11.7.3 Norgen Biotek Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Norgen Biotek Main Business Overview
11.7.5 Norgen Biotek Latest Developments
11.8 EXPRESS BIOTECH INTERNATIONAL, INC.
11.8.1 EXPRESS BIOTECH INTERNATIONAL, INC. Company Information
11.8.2 EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Product Offered
11.8.3 EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 EXPRESS BIOTECH INTERNATIONAL, INC. Main Business Overview
11.8.5 EXPRESS BIOTECH INTERNATIONAL, INC. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂